Search
27/02/2023
Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer
Chmielecki, J, Gray, JE, Cheng, Y, Ohe, Y, Imamura, F, Cho, BC, Lin, MC, Majem, M, Shah, R, Rukazenkov, Y, Todd, A, Markovets, A, Barrett, JC, Hartmaier, RJ, Ramalingam, SS. Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer. Nature Communications. 2023; 14(1)DOI:10.1038/s41467-023-35961-y. PMID:36849494. IF:14.700(Q1/1D).
27/02/2023
Percutaneous transhepatic biliary drainage for biliary obstruction in perihilar cholangiocarcinoma: a 10-year analysis of safety and outcomes using the CCI index
Paez-Carpio, A, Hessheimer, A, Bermudez, P, Zarco, FX, Serrano, E, Moreno, J, Molina, V, Ausania, F, Carrero, E, Burrel, M, Fondevila, C, Gomez, FM. Percutaneous transhepatic biliary drainage for biliary obstruction in perihilar cholangiocarcinoma: a 10-year analysis of safety and outcomes using the CCI index. LANGENBECKS ARCHIVES OF SURGERY. 2023; 408(1)DOI:10.1007/s00423-023-02852-1. PMID:36847837. IF:2.100(Q2/4D).
26/02/2023
Cardiovascular disease in women: Do we need new diagnostic and therapeutic strategies?
Jiménez-Quevedo P., Alonso-Martin C., Ruiz R.C., Guzmán-Martinez G., Perez M.P., Sambola A.. Cardiovascular disease in women: Do we need new diagnostic and therapeutic strategies?. POLISH HEART JOURNAL-KARDIOLOGIA POLSKA. 2023; 81(4)DOI:10.33963/KP.a2023.0051. PMID:36871309. IF:3.700(Q1/3D).
26/02/2023
A 37-Year-Old Man with Familial Hereditary Hemorrhagic Telangiectasia and Pulmonary Arteriovenous Malformations Presenting with Seizures and a Diagnosis of Brain Abscesses
Hernández-de Sosa N., Cardona Corrales R., Casademont J.. A 37-Year-Old Man with Familial Hereditary Hemorrhagic Telangiectasia and Pulmonary Arteriovenous Malformations Presenting with Seizures and a Diagnosis of Brain Abscesses. AMERICAN JOURNAL OF CASE REPORTS. 2023; 24DOI:10.12659/AJCR.938548. PMID:36841939. IF:(Q/D).
23/02/2023
Symptoms and Systemic Drug Reactions in Persons Receiving Weekly Rifapentine Plus Isoniazid (3HP) Treatment for Latent Tuberculosis Infection
Sadowski, C, Belknap, R, Holland, DP, Moro, RN, Chen, MP, Wright, A, Millet, JP, Cayla, JA, Scott, NA, Borisov, A, Gandhi, NR. Symptoms and Systemic Drug Reactions in Persons Receiving Weekly Rifapentine Plus Isoniazid (3HP) Treatment for Latent Tuberculosis Infection. CLINICAL INFECTIOUS DISEASES. 2023; 76(12)DOI:10.1093/cid/ciad083. PMID:36815322. IF:8.200(Q1/1D).
23/02/2023
Severe community-acquired Streptococcus pneumoniae bacterial meningitis: clinical and prognostic picture from the intensive care unit
Martin-Cerezuela, M, Aseginolaza-Lizarazu, M, Boronat-Garcia, P, Asensio-Martin, MJ, Alaman-Laguarda, G, Alvarez-Lerma, F, Roa-Alonso, D, Socias, L, Vera-Artazcoz, P, Ramirez-Galleymore, P. Severe community-acquired Streptococcus pneumoniae bacterial meningitis: clinical and prognostic picture from the intensive care unit. CRITICAL CARE. 2023; 27(1)DOI:10.1186/s13054-023-04347-3. PMID:36823625. IF:8.800(Q1/1D).